Sale!

FGFR2 Gene Crouzon Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGFR2 Gene Crouzon Syndrome Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the FGFR2 gene, which are associated with Crouzon Syndrome. This condition is a genetic disorder characterized by the premature fusion of certain skull bones, leading to an abnormal shape of the head and face. Symptoms may include wide-set, bulging eyes, a beaked nose, underdeveloped upper jaw, and dental problems.

This test is crucial for early detection and management of the syndrome, enabling healthcare providers to plan appropriate treatments and interventions to improve the quality of life for affected individuals. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the FGFR2 gene.

The cost of the FGFR2 Gene Crouzon Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment in genetic testing can provide families with vital information regarding the condition, potential treatments, and the risk of passing the syndrome to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FGFR2 Gene Crouzon Syndrome Genetic Test

At DNA Labs UAE, we offer the FGFR2 Gene Crouzon Syndrome Genetic Test, a comprehensive genetic test that analyzes the FGFR2 gene for mutations associated with Crouzon syndrome.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information

Before undergoing the FGFR2 Gene Crouzon Syndrome Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by Crouzon syndrome. This session will help in understanding the inheritance pattern and guide the testing process.

Test Details

The FGFR2 gene Crouzon Syndrome NGS genetic test is specifically designed to identify mutations associated with Crouzon syndrome. Crouzon syndrome is a rare genetic disorder characterized by abnormal growth of the skull and facial bones, resulting in facial deformities and potential complications with vision, hearing, and breathing.

NGS, or next-generation sequencing, is a high-throughput sequencing technology used in this test. It allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of Crouzon syndrome, NGS technology helps identify mutations or variations in the FGFR2 gene, which is known to be associated with the condition.

The FGFR2 gene provides instructions for making a protein called fibroblast growth factor receptor 2. Mutations in this gene can disrupt the normal development and growth of bones and tissues in the skull and face, leading to the characteristic features of Crouzon syndrome.

To perform the FGFR2 Gene Crouzon Syndrome NGS genetic test, a DNA sample is required. This can be obtained through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the FGFR2 gene.

The results of the test are crucial in confirming a diagnosis of Crouzon syndrome and providing valuable information for treatment and management options. It is important to note that genetic testing for Crouzon syndrome should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

By offering the FGFR2 Gene Crouzon Syndrome Genetic Test, DNA Labs UAE aims to contribute to the early detection and management of Crouzon syndrome, ultimately improving the quality of life for affected individuals and their families.

Test Name FGFR2 Gene Crouzon syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FGFR2 Gene Crouzon syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR2 Gene Crouzon syndrome NGS Genetic DNA Test gene FGFR2
Test Details

FGFR2 gene Crouzon syndrome NGS genetic test is a type of genetic test that analyzes the FGFR2 gene for mutations associated with Crouzon syndrome. Crouzon syndrome is a rare genetic disorder characterized by abnormal growth of the skull and facial bones, leading to facial deformities and potential complications with vision, hearing, and breathing.

NGS, or next-generation sequencing, is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of Crouzon syndrome, NGS can be used to identify mutations or variations in the FGFR2 gene, which is known to be associated with the condition.

The FGFR2 gene provides instructions for making a protein called fibroblast growth factor receptor 2. Mutations in this gene can disrupt the normal development and growth of bones and tissues in the skull and face, leading to the characteristic features of Crouzon syndrome.

The FGFR2 gene Crouzon syndrome NGS genetic test involves obtaining a DNA sample, typically through a blood sample or a cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the FGFR2 gene. The results of the test can help confirm a diagnosis of Crouzon syndrome and provide valuable information for treatment and management options.

It is important to note that genetic testing for Crouzon syndrome should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.